Trauma remains an important problem in American life, accounting for a truly staggering loss of productive years, and consuming a parallel share of health care resources. The morbidity and mortality after 24 hours is closely related to a syndrome of multi-system organ failure. This syndrome has become a major focus point for research because of the wide range of derangements which occur at a cellular level, and because the evolution of our insights into the molecular mechanisms and the integrative biology of acute inflammatory disease are so graphically illustrated in post-traumatic multi-system failure. There is considerable optimism that this basic research will ultimately lead to specific and novel forms of preventive and/or curative therapy. There is a growing concern, however, for a disproportion between the pace of expansion of basic knowledge of cellular and molecular processes that might serve therapeutic ends and the actual translation of that work into clinical settings. Conversely, the availability of physician-scientists able to evaluate and translate concepts from this rapidly evolving science into clinically relevant settings is decreasing. The possibility of an increasing discordance here is of grave concern because implicit delays in application of new discoveries to clinical settings. Our training program is designed as a means of producing both M.D. and Ph.D. scientists who participate in the dialogue between clinical and basic science. We believe that the individuals should have the skill sets needed to obtain future NIH funding, including the ability to partner with other scientists and to fully understand the responsible conduct of research. We believe that the best training environment for post-doctoral trainees is in a matrix including both clinical and basic scientists, an intellectual network supporting our programmatic research goals. We have worked to ensure the quality of mentoring these trainees receive, and have closely examined the outcomes of our past trainees. We have, over the fifteen years that this program has been in existence, had considerable experience in the intricacies of these tasks, and believe we have had considerable success. This program has evolved into a strong partnership between our trauma, cardiovascular, and anesthesia research groups at the University of Cincinnati College of Medicine and the critical care, surgical and pulmonary biology groups at Cincinnati Children's Hospital and Medical Center. We have added junior researchers in these groups who have recently obtained NIH funding, and have organized a leadership transition plan for this program.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM008478-20
Application #
8282730
Study Section
Special Emphasis Panel (ZGM1-BRT-5 (TA))
Program Officer
Somers, Scott D
Project Start
1993-07-01
Project End
2013-06-30
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
20
Fiscal Year
2012
Total Cost
$146,026
Indirect Cost
$18,907
Name
University of Cincinnati
Department
Surgery
Type
Schools of Medicine
DUNS #
041064767
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Quillin 3rd, Ralph C; Wilson, Gregory C; Nojima, Hiroyuki et al. (2015) Inhibition of acidic sphingomyelinase reduces established hepatic fibrosis in mice. Hepatol Res 45:305-14
Kuethe, Joshua W; Mintz-Cole, Rachael; Johnson 3rd, Bobby L et al. (2014) Assessing the immune status of critically ill trauma patients by flow cytometry. Nurs Res 63:426-34
Kuethe, Joshua W; Prakash, Priya S; Midura, Emily F et al. (2014) Thymic stromal lymphopoietin mediates the host response and increases mortality during sepsis. J Surg Res 191:19-24
Richter, Jillian R; Sutton, Jeffrey M; Belizaire, Ritha M et al. (2014) Macrophage-derived chemokine (CCL22) is a novel mediator of lung inflammation following hemorrhage and resuscitation. Shock 42:525-31
Atkinson, Sarah J; Wong, Hector R (2014) Identifying critically ill patients who may benefit from adjunctive corticosteroids: not as easy as we thought. Pediatr Crit Care Med 15:769-71
Sutton, Jeffrey M; Pritts, Timothy A (2014) Human beta-defensin 3: a novel inhibitor of Staphylococcus-produced biofilm production. Commentary on "Human *-defensin 3 inhibits antibiotic-resistant Staphylococcus biofilm formation". J Surg Res 186:99-100
Yang, Sung; Stepien, David; Hanseman, Dennis et al. (2014) Substance P mediates reduced pneumonia rates after traumatic brain injury. Crit Care Med 42:2092-100
Atkinson, Sarah J; Cvijanovich, Natalie Z; Thomas, Neal J et al. (2014) Corticosteroids and pediatric septic shock outcomes: a risk stratified analysis. PLoS One 9:e112702
Johnson 3rd, Bobby L; Goetzman, Holly S; Prakash, Priya S et al. (2013) Mechanisms underlying mouse TNF-* stimulated neutrophil derived microparticle generation. Biochem Biophys Res Commun 437:591-6
Yang, Sung H; Gangidine, Matt; Pritts, Timothy A et al. (2013) Interleukin 6 mediates neuroinflammation and motor coordination deficits after mild traumatic brain injury and brief hypoxia in mice. Shock 40:471-5

Showing the most recent 10 out of 77 publications